In just over 90 days of identification of a pneumonia of unknown cause, the novel coronavirus pandemic, which is raging around the world and posing a challenge for all countries and regions. As on April 2,2020 the number of confirmed COVID-19 cases worldwide has risen above 1 million, according to the new tally from Johns Hopkins University. Since the emergence of the novel coronavirus (COVID-19), biopharmaceutical companies across the world have stepped up their research efforts to develop vaccines and treatments in order to contain the virus. As of March 26, 2020, there are a number of therapeutics currently in clinical trials and more than 52 candidate vaccines are in preclinical evaluation for COVID-19 and 2 candidate vaccines are in clinical evaluation. Over 80 clinical trials are underway to test new and existing medicines across the globe.